These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30701868)

  • 1. Frequency of detection of some markers of endothelial dysfunction in patients with inflammatory bowel diseases.
    Babayeva GH; Babayev ZM
    Ter Arkh; 2018 Apr; 90(4):12-16. PubMed ID: 30701868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine in patients with inflammatory bowel diseases.
    Owczarek D; Cibor D; Sałapa K; Jurczyszyn A; Mach T
    Przegl Lek; 2014; 71(4):189-92. PubMed ID: 25141576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum nitrate levels in ulcerative colitis and Crohn's disease.
    Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
    Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
    Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G
    Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial function and cardiovascular risk in active inflammatory bowel diseases.
    Principi M; Mastrolonardo M; Scicchitano P; Gesualdo M; Sassara M; Guida P; Bucci A; Zito A; Caputo P; Albano F; Ierardi E; Di Leo A; Ciccone MM
    J Crohns Colitis; 2013 Nov; 7(10):e427-33. PubMed ID: 23473915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defense mechanisms in inflammatory bowel disease.
    Hyphantis TN; Triantafillidis JK; Pappa S; Mantas C; Kaltsouda A; Cherakakis P; Alamanos Y; Manousos ON; Mavreas VG
    J Gastroenterol; 2005 Jan; 40(1):24-30. PubMed ID: 15692786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease.
    Miranda-García P; Chaparro M; Gisbert JP
    Gastroenterol Hepatol; 2016 Oct; 39(8):508-15. PubMed ID: 27020243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
    Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
    Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
    Diederen K; Hoekman DR; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Vlieger AM; Kindermann A; Benninga MA
    Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
    Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
    Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease.
    Mahmud N; McDonald GS; Kelleher D; Weir DG
    Gut; 1996 Jan; 38(1):99-103. PubMed ID: 8566867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SYSTEMIC INFLAMMATION MARKERS AND MICROALBUMINURIA IN INFLAMMATORY BOWEL DISEASES].
    Stepina EA; Koposova KA; Khlynova OV; Tuev AV; Vasilets LV
    Eksp Klin Gastroenterol; 2016; (3):15-9. PubMed ID: 27301137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Small Intestinal Transit Times in Ulcerative Colitis and Crohn's Disease Patients with Different Disease Activity Using Video Capsule Endoscopy.
    Fischer M; Siva S; Wo JM; Fadda HM
    AAPS PharmSciTech; 2017 Feb; 18(2):404-409. PubMed ID: 27032935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS.
    Nóbrega VG; Silva INN; Brito BS; Silva J; Silva MCMD; Santana GO
    Arq Gastroenterol; 2018; 55(3):290-295. PubMed ID: 30540094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
    Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
    Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity C-reactive protein in paediatric inflammatory bowel disease.
    Sidoroff M; Karikoski R; Raivio T; Savilahti E; Kolho KL
    World J Gastroenterol; 2010 Jun; 16(23):2901-6. PubMed ID: 20556836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette smoking and quality of life in patients with inflammatory bowel disease. South Limburg IBD Study Group.
    Russel MG; Nieman FH; Bergers JM; Stockbrügger RW
    Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1075-81. PubMed ID: 8944369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I; Fedak D; Mach T
    Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.